In order to experimentally evaluate if some of these predicted targets could act as miR-21 targets in the context of pancreatic cancer, we selected 2 targets (PDCD4, BTG2) from the top miR-21 targets list (Table 4). This evidence concerns the gene BTG2 and familial pancreatic carcinoma.